原推:Exact Sciences highlights the underlying profitability of many companies investing aggressively NOW to capitalize on exponential growth opportunities, in this case disrupting cancer. Exact’s gross margin is 73.8% compared to 43.6% for the Nasdaq and 34.1% for the S&P 500. https://t.co/N0pQM12I7p